The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...

Researchers say bisphenols, PFAS and flame retardants can still be present in some food packaging, and highly processed foods are contaminated by plastic chemicals on their route from a factory to a ...

Study shows that exhaled volatile organic compounds, including propanoic and nonanoic acids, could be used as non-invasive ...

FDA approves 2-dose biologic Exdensur for severe eosinophilic asthma in patients 12 and older, reducing exacerbations and hospital visits.